A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/18/2011	US20110197969 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
08/18/2011	DE102010008644A1 Zyklische Ketoenole zur Therapie Cyclic ketoenols for therapy
08/18/2011	DE102010008643A1 New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumor
08/18/2011	DE102010008642A1 New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumors
08/18/2011	DE102010007958A1 Wirkstoffkombinationen aus Acylarginaten und quaternären Ammoniumverbindungen Active compound combinations of Acylarginaten and quaternary ammonium compounds
08/18/2011	DE102009022066A1 Alcohol compound useful as a substitute for hemoglobin in an artificial blood
08/18/2011	CA2827015A1 Hybrid molecule having mixed retinoic acid receptor agonism and histone deacetylase inhibitory properties
08/18/2011	CA2825428A1 Compositions and methods for treating depression
08/18/2011	CA2789989A1 Process for the preparation of alpha form of imatinib mesylate
08/18/2011	CA2789847A1 Kinase modulators for the treatment of cancer
08/18/2011	CA2789806A1 5-ht receptor modulators
08/18/2011	CA2789663A1 5-ht4 receptor agonists for the treatment of dementia
08/18/2011	CA2789595A1 Methods and compositions to improve mechanical resistance of teeth
08/18/2011	CA2789551A1 Cyclic keto-enols for therapy
08/18/2011	CA2789517A1 Use of the lactosylceramide synthase isoform b1,4galt-v as a biomarker for cancer
08/18/2011	CA2789434A1 Benzisoxazoles and azabenzisoxazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/18/2011	CA2789427A1 Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/18/2011	CA2789344A1 Synthesis of bicyclic compounds and method for their use as therapeutic agents
08/18/2011	CA2789298A1 Preparation process of the sodium salt of esomeprazole
08/18/2011	CA2789276A1 New signaling molecule involved in ultraviolet damage to skin
08/18/2011	CA2789240A1 Progesterone receptor antagonists
08/18/2011	CA2789237A1 Progesterone receptor antagonists
08/18/2011	CA2789229A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
08/18/2011	CA2789195A1 Derivatives of betulin
08/18/2011	CA2789082A1 Use of agomelatine for the preparation of drugs for treating obsessive compulsive disorder (ocd)
08/18/2011	CA2788834A1 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom
08/18/2011	CA2788761A1 Sanglifehrin based compounds
08/18/2011	CA2788533A1 Salt of fused heterocyclic derivative and crystal thereof
08/18/2011	CA2788459A1 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
08/18/2011	CA2788284A1 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase
08/18/2011	CA2788236A1 Substituted pyrrolidine-2-carboxamides
08/18/2011	CA2787881A1 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
08/18/2011	CA2787823A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
08/18/2011	CA2786973A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/18/2011	CA2786550A1 Removal of virulence factors through extracorporeal therapy
08/18/2011	CA2786230A1 A novel boswellia low polar gum resin extract and its synergistic compositions
08/18/2011	CA2780922A1 7-aminofuropyridine derivatives
08/17/2011	EP2357474A1 Lurasidone for use in the treatment of memory or learning dysfunction by schizophrenia
08/17/2011	EP2357249A1 Macrolide compounds
08/17/2011	EP2357236A2 compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357235A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357234A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357233A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357232A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357231A2 Stabilized immune modulatory RNA (SIMRA) compounds
08/17/2011	EP2357200A1 Human antibodies that bind human TNFalpha
08/17/2011	EP2357184A1 Imidazoquinoxaline compounds as immunomodulators
08/17/2011	EP2357183A1 Morphinan compounds
08/17/2011	EP2357182A1 Inhibitors of tyrosine kinases
08/17/2011	EP2357181A1 2,4-Diaminopyrimidines as inhibitors of cell cycle kinases
08/17/2011	EP2357179A1 Thiazol-2-yl organic compounds
08/17/2011	EP2357176A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
08/17/2011	EP2357175A1 isoquinoline derivatives AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN
08/17/2011	EP2357174A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
08/17/2011	EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011	EP2357171A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
08/17/2011	EP2357170A1 Processes and intermediates
08/17/2011	EP2357166A1 Auto magnetic metal salen complex compound
08/17/2011	EP2357165A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders
08/17/2011	EP2357003A2 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
08/17/2011	EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/17/2011	EP2356990A2 Liposome treatment of viral infections
08/17/2011	EP2356989A1 Stable tablet containing 4,5-epoxymorphinan derivative
08/17/2011	EP2356988A1 Therapeutic agent for chorioretinal degenerative diseases comprising pyridine-3-carbaldehyde o-(piperidin-1-yl-propyl)-oxime derivative as active ingredient
08/17/2011	EP2356987A1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol
08/17/2011	EP2356986A1 Composition for treatment of metabolic syndrome
08/17/2011	EP2356985A1 Novel pharmaceutical compositions comprising a combination of metformin and sitagliptin
08/17/2011	EP2356984A1 Improved distigmine bromide formulation
08/17/2011	EP2356982A2 Antimicrobial compositions and methods
08/17/2011	EP2356979A1 Anti-wrinkle agents
08/17/2011	EP2356914A2 Composition for improving membrane composition and functioning of cells
08/17/2011	EP2356234A2 Dosage of oligonucleotides suitable for the treatment of tumors
08/17/2011	EP2356230A1 Cancer related gene, lgn/gpsm2
08/17/2011	EP2356130A1 Treatment of restless leg syndrome and sleep disorders
08/17/2011	EP2356129A1 Substituted alpha-l-bicyclic nucleosides
08/17/2011	EP2356128A1 Oligosaccharide compounds for use in mobilising stem cells
08/17/2011	EP2356125A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
08/17/2011	EP2356124A1 Gamma secretase modulators
08/17/2011	EP2356123A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
08/17/2011	EP2356122A1 Protein kinase inhibitors
08/17/2011	EP2356121A1 Process for resolving zopiclone
08/17/2011	EP2356120A1 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
08/17/2011	EP2356119A1 Peripheral opioid receptor antagonists and uses thereof
08/17/2011	EP2356117A1 Pyrazolopyridine pi3k inhibitor compounds and methods of use
08/17/2011	EP2356116A1 Substituted pyrroloý2,3-b¨-pyridines and-pyrazines
08/17/2011	EP2356115A1 Gamma secretase modulators
08/17/2011	EP2356114A1 Aminoalkyl-substituted compounds as hif inhibitors
08/17/2011	EP2356113A1 Heterocyclically substituted aryl compounds as hif inhibitors
08/17/2011	EP2356112A1 Heteroaromatic compounds for use as hif inhibitors
08/17/2011	EP2356111A1 Compounds for the treatment of inflammatory disorders
08/17/2011	EP2356109A2 Compositions and methods for treating alcohol use disorders, pain and other diseases
08/17/2011	EP2356108A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
08/17/2011	EP2356106A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
08/17/2011	EP2356105A1 ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain
08/17/2011	EP2356103A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
08/17/2011	EP2356101A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain
08/17/2011	EP2356099A1 Tetrahydrofuranyl sulfonamides for use as ampa modulators in the treatment of cns disorders
08/17/2011	EP2356097A2 Highly pure ranolazine or a pharmaceutically acceptable salt thereof
08/17/2011	EP2356094A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
08/17/2011	EP2356093A1 Carbazole compounds and therapeutic uses of the compounds

1 ... 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 ... 7860